Trials / Withdrawn
WithdrawnNCT06034899
A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants
A Phase 1, 2-part, Open-label, Randomized, 2-period, 2-sequence, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-986196 Phase 2 Tablet Formulation at Two Dose Levels in Healthy Adult Participants
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the drug levels of BMS-986196 and to evaluate the effect of food (fasted versus fed \[high-fat meal\]) on the drug levels after administration of BMS-986196 tablet formulation at two dose levels in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986196 | Specified dose on specified days |
Timeline
- Start date
- 2023-09-22
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2023-09-13
- Last updated
- 2023-09-21
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06034899. Inclusion in this directory is not an endorsement.